FDA

Archive
31 October 2024

Insomnia app unavailable for most of NHS despite NICE approval

Big Health says that its app to treat insomnia is unavailable to most NHS patients despite being recommended by NICE
Read More
A photo showing a birds-eye view of a cup of coffee, with the words "Digital Health coffee time" in white text overlaid in the foreground
19 September 2024

Digital Health Coffee Time Briefing ☕

Today's Coffee Time Briefing covers a new smart headband for PMS and menstrual pain and the busiest summer on record
Read More
Coffee Time Briefing
6 February 2024

Digital Health Coffee Time Briefing ☕

This briefing includes TidalSense developing AI-powered tech for COPD sufferers and Cyted receiving FDA clearance for its EndoSign cell collection
Read More
Coffee Time Briefing
11 December 2023

Digital Health Coffee Time Briefing ☕ 

Monday's briefing includes news that Belfast Trust will become the largest trust in Northern Ireland to use encompass - a
Read More
Coffee Time Briefing
24 November 2023

Digital Health Coffee Time Briefing ☕ 

Today's briefing covers the signing of a charter aimed at fostering healthcare innovation in Wales and Brainomix's continued expansion into
Read More
26 October 2023

Digital Health Coffee Time Briefing ☕

Thursday's coffee briefing features news from MHRA, FuturU, Lucida Medical Ltd and the opening of Topol Digital Fellowship applications.
Read More
13 October 2023

Digital Health Coffee Time Briefing ☕

This morning briefing includes news from the Department of Health and Social Care, NHS England and The Good Things Foundation.
Read More
12 June 2023

Exclusive: Huma receives US FDA Class II clearance for SaMD platform

A Software-as-a-Medical-Device platform from Huma has received US Food and Drug Administration Class II clearance, boosting innovation in digital health.
Read More
24 May 2023

NHS-backed Acurable to launch sleep apnoea testing device in the US

London-based medical device company Acurable is launching its AcuPebble device for Obstructive Sleep Apnoea (OSA) diagnosis in the US.
Read More
9 May 2023

Ultromics granted FDA Breakthrough Device Status

Ultromics has gained FDA Breakthrough Device Designation for its AI-powered EchoGo Amyloidosis platform, which is speeding up diagnosis.
Read More